NMLSF (Restart Life Sciences) Common Stock : $37.11 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Restart Life Sciences Common Stock?

Restart Life Sciences's quarterly common stock declined from Mar. 2024 ($37.13 Mil) to Jun. 2024 ($36.67 Mil) but then increased from Jun. 2024 ($36.67 Mil) to Sep. 2024 ($37.11 Mil).

Restart Life Sciences's annual common stock increased from Dec. 2020 ($37.66 Mil) to Dec. 2021 ($37.79 Mil) but then declined from Dec. 2021 ($37.79 Mil) to Dec. 2022 ($36.85 Mil).

Restart Life Sciences Common Stock Historical Data

The historical data trend for Restart Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Common Stock Chart

Restart Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Common Stock

Get a 7-Day Free Trial

20.29

20.88

37.66

37.79

36.85

Restart Life Sciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															-	37.10	37.13	36.67	37.11

Restart Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Restart Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (OTCPK:NMLSF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

HN3:Germany HN3:Germany HEAL.X:Canada

Address

700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6

Website

https://www.novamentis.ca

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).